Dataset: Expression data from Sotos syndrome patients and controls
Genome-wide expression studies were performed on dermal fibroblasts from Sotos syndrome patients with a confirmed NSD1 abnormality and...
Genome-wide expression studies were performed on dermal fibroblasts from Sotos syndrome patients with a confirmed NSD1 abnormality and compared with age-sex matched controls. We used microarrays to detect differentially expressed genes in Sotos syndrome patients and performed a global test with the aim to map NSD1 within a signaling transduction pathway. Dermal fibroblasts were obtained from nine Sotos syndrome patients and nine controls. Since NSD1 is a co-factor of the retinoic acid receptor, cultures were performed both in the presence and absence of retinoic acid.
- Species:
- human
- Samples:
- 36
- Source:
- E-GEOD-27200
- Updated:
- Dec.12, 2014
- Registered:
- Jul.11, 2014
Factors:
(via ArrayExpress)
Sample | DISEASE STATE | TREATMENT |
---|---|---|
GSM67206 | Sotos syndrome with NSD1 abnormality | RETINOIC ACID |
GSM672060 | Sotos syndrome with NSD1 abnormality | untreated |
GSM67206 | Sotos syndrome with NSD1 abnormality | RETINOIC ACID |
GSM672060 | Sotos syndrome with NSD1 abnormality | untreated |
GSM67206 | Sotos syndrome with NSD1 abnormality | RETINOIC ACID |
GSM672060 | Sotos syndrome with NSD1 abnormality | untreated |
GSM67206 | Sotos syndrome with NSD1 abnormality | RETINOIC ACID |
GSM672060 | Sotos syndrome with NSD1 abnormality | untreated |
GSM67206 | Sotos syndrome with NSD1 abnormality | RETINOIC ACID |
GSM672060 | Sotos syndrome with NSD1 abnormality | untreated |
GSM67206 | Sotos syndrome with NSD1 abnormality | RETINOIC ACID |
GSM672060 | Sotos syndrome with NSD1 abnormality | untreated |
GSM67206 | Sotos syndrome with NSD1 abnormality | RETINOIC ACID |
GSM672060 | Sotos syndrome with NSD1 abnormality | untreated |
GSM67206 | Sotos syndrome with NSD1 abnormality | RETINOIC ACID |
GSM672060 | Sotos syndrome with NSD1 abnormality | untreated |
GSM67206 | Sotos syndrome with NSD1 abnormality | RETINOIC ACID |
GSM672060 | Sotos syndrome with NSD1 abnormality | untreated |
GSM672043 | control | RETINOIC ACID |
GSM672042 | control | untreated |
GSM672043 | control | RETINOIC ACID |
GSM672042 | control | untreated |
GSM672043 | control | RETINOIC ACID |
GSM672042 | control | untreated |
GSM672043 | control | RETINOIC ACID |
GSM672042 | control | untreated |
GSM672043 | control | RETINOIC ACID |
GSM672042 | control | untreated |
GSM672043 | control | RETINOIC ACID |
GSM672042 | control | untreated |
GSM672043 | control | RETINOIC ACID |
GSM672042 | control | untreated |
GSM672043 | control | RETINOIC ACID |
GSM672042 | control | untreated |
GSM672043 | control | RETINOIC ACID |
GSM672042 | control | untreated |